Literature DB >> 16323116

Vancomycin resistance in gram-positive cocci.

Patrice Courvalin1.   

Abstract

The first vancomycin-resistant clinical isolates of Enterococcus species were reported in Europe in 1988. Similar strains were later detected in hospitals on the East Coast of the United States. Since then, vancomycin-resistant enterococci have spread with unexpected rapidity and are now encountered in hospitals in most countries. This article reviews the mode of action and the mechanism of bacterial resistance to glycopeptides, as exemplified by the VanA type, which is mediated by transposon Tn1546 and is widely spread in enterococci. The diversity, regulation, evolution, and recent dissemination of methicillin-resistant Staphylococcus aureus are then discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16323116     DOI: 10.1086/491711

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  247 in total

1.  Vancomycin C-Terminus Guanidine Modifications and Further Insights into an Added Mechanism of Action Imparted by a Peripheral Structural Modification.

Authors:  Zhi-Chen Wu; Michael D Cameron; Dale L Boger
Journal:  ACS Infect Dis       Date:  2020-07-14       Impact factor: 5.084

Review 2.  Current concepts in laboratory testing to guide antimicrobial therapy.

Authors:  Stephen G Jenkins; Audrey N Schuetz
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

Review 3.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

4.  Vancomycin-resistant Enterococci of vanB genotype may pose problems for screening with highly selective media.

Authors:  Hildegard Adler; Selda Oezcan; Reno Frei
Journal:  J Clin Microbiol       Date:  2010-04-21       Impact factor: 5.948

Review 5.  Evolving resistance among Gram-positive pathogens.

Authors:  Jose M Munita; Arnold S Bayer; Cesar A Arias
Journal:  Clin Infect Dis       Date:  2015-09-15       Impact factor: 9.079

6.  The Mechanism of Action of Lysobactin.

Authors:  Wonsik Lee; Kaitlin Schaefer; Yuan Qiao; Veerasak Srisuknimit; Heinrich Steinmetz; Rolf Müller; Daniel Kahne; Suzanne Walker
Journal:  J Am Chem Soc       Date:  2015-12-24       Impact factor: 15.419

Review 7.  Multidrug resistance in bacteria.

Authors:  Hiroshi Nikaido
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

8.  Vancomycin-variable Enterococcus faecium: in vivo emergence of vancomycin resistance in a vancomycin-susceptible isolate.

Authors:  Bryan Coburn; Donald E Low; Samir N Patel; Susan M Poutanen; Dea Shahinas; Alireza Eshaghi; Barbara M Willey; Allison McGeer
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

Review 9.  Total Syntheses of Vancomycin-Related Glycopeptide Antibiotics and Key Analogues.

Authors:  Akinori Okano; Nicholas A Isley; Dale L Boger
Journal:  Chem Rev       Date:  2017-04-24       Impact factor: 60.622

10.  Vancomycin-resistant gram-positive cocci isolated from the saliva of wild songbirds.

Authors:  Shingo Ishihara; Jessica J Bitner; Greg H Farley; Eric T Gillock
Journal:  Curr Microbiol       Date:  2012-12-06       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.